Gap Persists Between AI Discovery and Clinical Disease Cures
August 16, 2026
Current AI capabilities face a significant bottleneck in translating data center discoveries into clinical reality. Bridging the gap requires navigating long-term drug development cycles, including phase 3 trials that can take five years or more.
HOW THIS AFFECTS YOU
●
founderAvoid overpromising short-term therapeutic breakthroughs; regulatory and clinical hurdles remain the primary delay factors.
●
healthYou must account for multi-year clinical trial timelines when evaluating AI-driven drug discovery claims.